Delivered by Ingenta to: Florida State University, College of Medicine
IP: 5.8.47.242 On: Fri, 24 Jun 2016 07:31:30
Copyright: American Scientific Publishers
Copyright © 2007 American Scientific Publishers
All rights reserved
Printed in the United States of America
Journal of
Nanoscience and Nanotechnology
Vol. 7, 3700–3705, 2007
Anticancer Drug-Inorganic Nanohybrid and
Its Cellular Interaction
Ju Young Kim
1
, Soo-Jin Choi
1
, Jae-Min Oh
1 2
, Taeun Park
2
, and Jin-Ho Choy
1 ∗
1
Center for Intelligent Nano-Bio Materials (CINBM), Division of Nanoscience and
Department of Chemistry, Ewha Womans University, Seoul, 120-750, Korea
2
Nanohybrid Co. Ltd., Ewha Womans University, Seoul, 120-750, Korea
An anticancer drug, methotrexate (MTX), has been successfully hybridized with layered double
hydroxide (LDH) through co-precipitation route to produce MTX-LDH nanohybrids (MTX-LDH).
According to the X-ray diffraction and FT-IR spectroscopy, it was confirmed that MTX molecules are
stabilized in the interlayer space of LDHs by electrostatic interaction, maintaining their functional
groups and structural integrity. According to the drug release study, the total amount of released
MTX from the LDH lattice was determined to be larger under a simulated intracellular lysosomal
condition (pH = 4.5) than simulated body fluid one (pH = 7.4). It is, therefore, expected that the MTX
molecules in MTX-LDH can be effectively released in lysosomes, since the MTX release could be
accelerated via ion-exchange reaction and dissolution of LDH in an acidic lysosomal condition. We
also examined the anticancer efficacy of MTX-LDH in human breast adenocarcinoma MCF-7 cells.
The cellular uptake of MTX was considerably higher in MTX-LDH-treated cells than in free MTX-
treated cells, giving a lower IC
50
value for the former than the latter. All the results demonstrated
that the MTX-LDH nanohybrid allows the efficient drug delivery in cells, and thus enhances drug
efficacy.
Keywords: Layered Double Hydroxide (LDH), Hybrid Material, Anticancer Drug, Efficient Drug
Delivery, Methotrexate (MTX).
1. INTRODUCTION
Nanohybrid systems have attracted considerable interest
due to their potential applications in various fields, such as
catalyst, electronics, semiconductors, cosmetics, and drug
carriers.
1–6
In particular, bio-inorganic hybrid systems have
deeply fascinated chemists as well as biologists, since they
possess unique properties for biological applications by
providing stabilization, targeted delivery, and controlled
release of carried drugs and bio-active molecules.
7 8
Among various inorganic materials, layered double
hydroxides (LDHs), also known as anionic clays, are
promising candidates for drug delivery carriers. LDHs con-
sist of positively charged layers and interlayer charge-
compensating anions hydrated with water molecules. For a
decade, intercalation chemistry of LDHs has been rapidly
emerged with life sciences for biological applications. In
particular, it has been demonstrated that LDHs can be
a good candidate as the delivery carrier for DNA,
7 9 10
amino acid,
11 12
and drugs into cells,
8 13
since such an inor-
ganic layered carrier can provide not only an enhanced
∗
Author to whom correspondence should be addressed.
dissolution property,
8 15
thermal stability
16 17
and cellular
interaction and uptake
14
but also a controlled release
rate.
8 18
A well-known anticancer drug, methotrexate (MTX),
which inhibits DNA, RNA, and protein synthesis by acting
as a folate antagonist,
19
has been applied to certain human
cancers, such as osteosarcoma and leukemia. However,
due to very short plasma half-life and high efflux
rate compared to influx rate, high administration dose
was required. In order to overcome such demerits, we
attempted to encapsulate MTX into LDH carrier lattice to
form a hybridized MTX-LDH to get above mentioned
advantages of LDH such as enhanced cellular transport
and controlled drug release rate, particularly in cytosol and
lysosomal conditions. We also examined drug efficacy of
MTX-LDH by quantifying the cellular uptake of MTX in
MTX-LDH nanohybrid as compared to MTX only.
2. EXPERIMENTAL DETAILS
All chemical, Mg(NO
3
2
· 6H
2
O, Al(NO
3
3
· 9H
2
O, NaOH,
and MTX were purchased from Aldrich Co., Ltd.
Mg
068
Al
032
(OH)
2
(NO
3
032
· 0.1H
2
O was prepared by
3700 J. Nanosci. Nanotechnol. 2007, Vol. 7, No. 11 1533-4880/2007/7/3700/006 doi:10.1166/jnn.2007.061